Site 42 - Dana-Farber Cancer Institute, EDDC — Boston, Massachusetts

Site 42 - Dana-Farber Cancer Institute, EDDC is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 42 - Dana-Farber Cancer Institute, EDDC has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.

Sponsors: Carrick Therapeutics Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 42 - Dana-Farber Cancer Institute, EDDC?

Site 42 - Dana-Farber Cancer Institute, EDDC has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 42 - Dana-Farber Cancer Institute, EDDC conducted?

Site 42 - Dana-Farber Cancer Institute, EDDC has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.

Is Site 42 - Dana-Farber Cancer Institute, EDDC accredited by Crixeo Clinical Trials?

Site 42 - Dana-Farber Cancer Institute, EDDC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 42 - Dana-Farber Cancer Institute, EDDC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.